Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

Baruch Padeh Medical Center

Status: Withdrawn

Conditions: Premature Birth; Pregnancy

Treatments: Drug: Crinone Gel 8%

Study type: Interventional

Funder types: Other

Identifiers

NCT00329316

PTL Progesterone Perlitz.CTIL

Details and patient eligibility

About

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

Exclusion criteria

• No medications for PTL or any kind of progesterone.
• Cervical suture
• Multiple pregnancy